Kodiak Sciences Inc. KOD
32.35
(0.87)
(2.62%)
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 0.0×
Follow KOD
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
1.78 | 4.72 | 3.54 | 2.49 |
Net Debt/EBITDA |
1.29 | 4.12 | 3.17 | 2.08 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.54 | 0.69 | 0.69 | 0.70 | |
Capex/Depreciation |
(0.01) | (0.01) | (0.15) | (0.06) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
(0.62) | (0.74) | (0.66) | (0.74) | |
Cash per Share |
1.36 | 3.94 | 2.74 | 2.01 | |
Shareholders Equity per Share |
0.45 | 2.96 | 1.81 | 0.98 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.45 | 2.96 | 1.81 | 0.98 | |
Free Cash Flow |
(32.94) | (39.42) | (40.95) | (46.59) | |
Working Capital |
33.30 | 169.28 | 125.69 | 78.59 | |
Capital Expenditures |
(0.06) | (0.04) | (0.94) | (0.35) | |
Net Current Asset Value |
(118.65) | 20.67 | (18.65) | (64.36) | |
| Other line items | |||||
Quick Ratio |
1.70 | 4.61 | 3.42 | 2.39 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.62) | (0.74) | (0.65) | (0.74) | |
Capex per Share |
0.00 | 0.00 | (0.02) | (0.01) | |
Average Payables |
6.83 | 8.39 | 8.94 | 8.85 | |
Average Assets |
295.37 | 343.56 | 301.96 | 256.77 | |
Average Common Equity |
104.53 | 153.84 | 110.47 | 65.69 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates